According to our new research study on “Protein Expression Market Forecast to 2028 – COVID-19 Impact and Global Analysis – by product type, services, application, end-user,” the market is expected to reach US$ 4,000.67 million in 2028 from US$ 2,221.73 million in 2021. The market is estimated to grow with a CAGR of 8.8% from 2021-2028. The reagents segment is anticipated to grow significantly amid the forecast period. To generate reagent-NA complexes, a transfection reagent is added to the diluted nucleic acid (NA). The cells are seeded and then complexes are added to the newly seeded cells directly. Whereas, cells are plated 24 hours prior to transfection in a traditional transfection. The day before transfection, cells are seeded in culture medium containing serum and antibiotics and are incubated under normal growth conditions. DNA or siRNA in culture medium without serum is diluted the next day. To generate reagent-NA complexes, the transfection reagent is applied directly to the diluted DNA or siRNA. Many chemical transfection reagents have an ideal time window in which an optimal-diameter transfection complex is created. Depending on the quality of the reagent, this is usually between 5 and 30 minutes. In general, transfection reagents must be in contact with cells for a period of time before introducing some additional medium or removing the medium (to help minimize toxic effects of the reagent). The optimum time for transfection depends on the cell line, the transfection reagent and the nucleic acid used.
Get PDF Brohure at https://www.theinsightpartners.com/sample/TIPHE100001247/
Based on product type, the protein expression market is segmented into instruments, reagents, expression vectors, and competent cells. The reagents segment held the largest share of the market in 2021. Also, the reagents segment is estimated to register the highest CAGR of 9.5% in the market during the forecast period.
Based on services, the protein expression market is segmented into antibody development production, protein expression production, hybridoma one-stop services, stable cell line development, bioanalytical assay services. The antibody development production segment held the largest share of the market in 2021. However, same segment is estimated to register the highest CAGR of 9.7% in the market during the forecast period.
Based on application, the protein expression market is segmented into research, therapeutic, industrial. The therapeutic segment held the largest share of the market in 2021 and same segment is estimated to register the highest CAGR of 9.4% in the market during the forecast period.
Based on end user, the protein expression market is segmented into pharmaceutical and biotechnology companies, academic research institutes, and contract research organizations. The pharmaceutical and biotechnology companies segment held the largest share of the market in 2021. Also, the segment is estimated to register the highest CAGR of 5.6% in the market during the forecast period.
Top Companies Analysis-
Thermo Fisher Scientific, Inc., GenScript, Merck KGaA, Agilent Technologies, Inc., Takara Bio Inc., Bio-Rad Laboratories, Inc., QIAGEN, New England Biolabs.,, Promega Corporation, and Oxford Expression Technologies Ltd amongst others. The companies are adopting inorganic and organic growth strategies to expand their global footprints and product portfolio to meet the rising demands for the Protein Expression. For instance, in May 2020, Thermo Fisher Scientific to Acquired QIAGEN N.V. Benefits of the Transaction are Expands Specialty Diagnostics Portfolio with Attractive Molecular Diagnostics Capabilities, Including Infectious Disease Testing, Complementary Offering Enhances Unique Value Proposition for Life Sciences Customers, Commercial and Geographic Reach Expand Customer Access, Delivers Attractive Financial Benefits through the PPI Business System, Including Proven Integration Approach.
About Us:
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.
Contact Us:
If you have any queries about this report or if you would like further information, please contact us:
Contact Person: Sameer Joshi
E-mail: [email protected]
Phone: +1-646-491-9876
